Dyslipidemia Completed Phase 3 Trials for TAK-475 (DB05317)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00143663Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated CholesterolTreatment
NCT00487994Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaTreatment